Amgros 2027 1.1462.a

Summary

The tender concerns medicines, specifically selpercatinib tablets/capsules in strengths of 40 mg and 80 mg. It is a framework agreement for Amgros to supply hospital pharmacies; the agreement is non-exclusive and there is no purchase obligation. The bidder should note that this is an open procedure and that the exact compliance and performance requirements must be checked in the tender documents.